ADMA Biologics, Inc.
NasdaqGM:ADMA
Sector
Industries
Location
Market Cap
USD 4.25 B
Share Price
USD 17.01
Avg Daily Volume
3,070,085
Change (1 day)
-4.44%
Change (1 year)
-7.55%
Change (YTD)
-0.82%
ADMA Biologics, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2021: -71.69%
ADMA Biologics, Inc. Return on Equity (ROE) is -71.69% for the Trailing 12 Months (TTM) ending September 30, 2021, a -27.45% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
-
ADMA Biologics, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2020 was -98.83%, a -50.00% change year over year.
-
ADMA Biologics, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending September 30, 2019 was -197.66%.
StockViz
Competitors
Eli Lilly and Company
USD 695.33
LLY
-16.35
-2.30%
AbbVie Inc.
USD 207.55
ABBV
-3.05
-1.45%
Roche Holding AG
USD 337.44
RO.SW
-3.52
-1.03%
Novo Nordisk A/S
USD 57.04
NOVO-B.CO
+0.05
0.10%
Novartis AG
USD 125.60
NOVN.SW
-1.46
-1.15%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Abbott Laboratories
USD 131.87
ABT
-0.72
-0.54%
Merck & Co., Inc.
USD 85.31
MRK
-2.06
-2.36%
Thermo Fisher Scientific Inc.
USD 490.75
TMO
-9.24
-1.85%
Amgen Inc.
USD 288.47
AMGN
-5.25
-1.79%
Pfizer Inc.
USD 25.14
PFE
-0.74
-2.86%
Gilead Sciences, Inc.
USD 114.15
GILD
-0.62
-0.54%
Sanofi
USD 100.24
SAN.PA
-2.14
-2.09%
Vertex Pharmaceuticals Incorporated
USD 388.94
VRTX
-6.18
-1.56%
Bristol-Myers Squibb Company
USD 47.14
BMY
-0.78
-1.63%
Key Data
| Date | Return on Equity (ROE) | Return on Assets (ROA) | Revenue Per Share | Free Cash Flow Per Share |
|---|
Competitors
Eli Lilly and Company
USD 695.33
LLY
-16.35
-2.30%
AbbVie Inc.
USD 207.55
ABBV
-3.05
-1.45%
Roche Holding AG
USD 337.44
RO.SW
-3.52
-1.03%
Novo Nordisk A/S
USD 57.04
NOVO-B.CO
+0.05
0.10%
Novartis AG
USD 125.60
NOVN.SW
-1.46
-1.15%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Abbott Laboratories
USD 131.87
ABT
-0.72
-0.54%
Merck & Co., Inc.
USD 85.31
MRK
-2.06
-2.36%
Thermo Fisher Scientific Inc.
USD 490.75
TMO
-9.24
-1.85%
Amgen Inc.
USD 288.47
AMGN
-5.25
-1.79%
Pfizer Inc.
USD 25.14
PFE
-0.74
-2.86%
Gilead Sciences, Inc.
USD 114.15
GILD
-0.62
-0.54%
Sanofi
USD 100.24
SAN.PA
-2.14
-2.09%
Vertex Pharmaceuticals Incorporated
USD 388.94
VRTX
-6.18
-1.56%
Bristol-Myers Squibb Company
USD 47.14
BMY
-0.78
-1.63%